Related Experiment Videos

PACT is required for MDA5-mediated immunoresponses triggered by Cardiovirus infection via interaction with LGP2

Masahiko Miyamoto1, Akihiko Komuro1

  • 1Department of Biochemistry, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata 956-8603, Japan.

Insights

The protein PACT interacts with LGP2 and MDA5 to enhance antiviral responses against Cardiovirus. This discovery may lead to new therapies for autoimmune diseases and cancer.

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • Laboratory of genetics and physiology 2 (LGP2) and melanoma differentiation-associated gene 5 (MDA5) detect viral RNA and trigger innate immunity.
  • The role of the double-stranded RNA-binding protein PACT in this antiviral pathway was unclear.

Purpose of the Study:

  • To investigate the role of PACT in the antiviral response mediated by LGP2 and MDA5.
  • To elucidate the mechanism of PACT's involvement in Cardiovirus detection and immune activation.

Main Methods:

  • Immunoprecipitation assays to detect protein interactions.
  • In vitro interaction analyses with recombinant proteins.
  • Small interfering RNA (siRNA) knockdown experiments.
  • Interferon promoter activity assays.

Main Results:

  • PACT directly interacts with LGP2, and this interaction is strengthened by encephalomyocarditis virus (EMCV) infection.
  • The single-stranded Theiler's murine encephalitis virus genome enhances the LGP2-PACT interaction.
  • PACT is essential for Cardiovirus-induced interferon responses, as shown by siRNA knockdown.
  • PACT enhances EMCV-triggered interferon promoter activity only when LGP2 and MDA5 are co-expressed.

Conclusions:

  • PACT plays a significant role in regulating Cardiovirus-triggered innate immune responses via the LGP2-MDA5 pathway.
  • These findings suggest potential therapeutic strategies targeting PACT for interferon-related autoimmune diseases and cancer.

Related Concept Videos